Zim Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

108.77

-2.49 (-2.24%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

108.77

-2.49 (-2.24%)
16:02 Dec 20

Quality

39/100
Medium Financial Strength

Valuation

47/100
Mid Valuation

Technical

53/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	307.26	333.43	398.53	367.42	388.11
Operating Expenses +	267.5	292.45	346.54	326.1	343.38
Raw Material	159.74	170.02	182.37	185.5	182.46
Increase Decrease in Cost	-1.11	-9.67	16.46	-14.05	-3.7
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	35.76	40.07	49.32	53.34	57.84
Miscellaneous Expenses	86.95	110.85	133.17	116.91	106.78
Operating Profit	39.76	40.98	51.99	41.32	44.73
Other Income	2.34	4.4	6.41	5.18	4.96
Depreciation	15.79	16.03	17.47	15.95	17.79
Interest	10.9	8.31	5.58	6.92	9.73
Profit before tax and exceptio..	15.41	21.04	35.36	23.64	22.17
Exceptional Items	-5.18	0	0	0	0
PBT	10.23	21.04	35.36	23.64	22.17
Provision for Taxation	2.91	6.49	10.92	6.4	6.06
Net Profit	7.32	14.55	24.43	17.25	16.15
NET Profit after MI	7.32	14.55	24.43	17.25	16.15
EPS	4.5	8.96	5.01	3.54	3.31
Operating Profit Margin (%)	12.94	12.29	13.05	11.25	11.53
Net Profit Margin (%)	2.38	4.36	6.13	4.69	4.16

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	33.30	33.30	33.30	33.30	33.30
FII	0.00	0.00	0.00	0.00	0.00
MF	0.00	0.00	0.00	0.00	0.00
Public	66.60	66.60	66.70	66.70	66.80
Others	0.00	0.00	0.00	0.00	0.00
Others	0.10	0.10	0.00	0.00	-0.10